CANbridge Pharmaceuticals (MF1.F) Q3 2025 Earnings

Aug 31Confirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
-0.07
-0.04
-0.01
0.02

Details

Expected EPS
N/A
Actual EPS
0.01671175443
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨CANbridge Pharmaceuticals⁩ (⁦MF1.F⁩) has reported earnings of ⁦0.01671175443⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts